100 Albert Road
Australia - Map
Phone: 61 3 9670 3273
Fax: 61 3 9670 3247
Patrys Limited, together with its subsidiaries, develops natural human antibody therapeutics for the treatment of cancer in Australia. The companys clinical products include PAT-SM6, a natural human antibody used for the treatment of various types of cancer, including solid tumors, such as melanoma, breast, colon, and pancreatic, as well as blood-based cancers that include multiple myeloma; and PAT-SC1, an antibody for treating gastric cancer. Its late stage preclinical products comprise PAT-LM1, a natural human antibody, which is used in the treatment of colon, lung, breast, ovary, and pancreatic cancers. The company was founded in 2006 and is based in South Melbourne, Australia.
|Dr. James A. Campbell BSc, Ph.D., MBA,
Chief Exec. Officer, Managing Director and Director
|Dr. Deanne Greenwood Ph.D., MBA,
VP of Bus. Devel. & Intellectual Property
|Ms. Melanie Jaye Leydin B.Bus (Acc/Law), CA,
|Ms. Valentina Dubljevic MBB, BSc ,
VP of Scientific & Clinical Devel.
|Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in AUD.|